A phase I dose-escalation study of danusertib (PHA-739358) administered as a 24-hour infusion with and without granulocyte colony-stimulating factor in a 14-day cycle in patients with advanced solid tumors (Q33676809)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I dose-escalation study of danusertib (PHA-739358) administered as a 24-hour infusion with and without granulocyte colony-stimulating factor in a 14-day cycle in patients with advanced solid tumors |
scientific article |
Statements
1 reference
A phase I dose-escalation study of danusertib (PHA-739358) administered as a 24-hour infusion with and without granulocyte colony-stimulating factor in a 14-day cycle in patients with advanced solid tumors (English)
1 reference
Margaret von Mehren
1 reference
Roger B Cohen
1 reference
Suzanne F Jones
1 reference
Charu Aggarwal
1 reference
Jonathan Cheng
1 reference
David R Spigel
1 reference
F Anthony Greco
1 reference
Mariangela Mariani
1 reference
Maurizio Rocchetti
1 reference
Roberta Ceruti
1 reference
Silvia Comis
1 reference
Bernard Laffranchi
1 reference
Jurgen Moll
1 reference
Howard A Burris
1 reference
13 October 2009
1 reference
1 reference
15
1 reference
21
1 reference
6694-6701
1 reference
Identifiers
1 reference
1 reference
1 reference